Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells.

Sachdev D, Hartell JS, Lee AV, Zhang X, Yee D.

J Biol Chem. 2004 Feb 6;279(6):5017-24. Epub 2003 Nov 13.

2.

The insulin-like growth factor system and cancer.

LeRoith D, Roberts CT Jr.

Cancer Lett. 2003 Jun 10;195(2):127-37. Review.

PMID:
12767520
3.

IGF-I receptor signalling: lessons from the somatotroph.

Melmed S, Yamashita S, Yamasaki H, Fagin J, Namba H, Yamamoto H, Weber M, Morita S, Webster J, Prager D.

Recent Prog Horm Res. 1996;51:189-215; discussion 215-6. Review.

PMID:
8701079
4.

IGF1R signalling and its inhibition.

Riedemann J, Macaulay VM.

Endocr Relat Cancer. 2006 Dec;13 Suppl 1:S33-43. Review.

5.
6.
7.

Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment.

Bohula EA, Playford MP, Macaulay VM.

Anticancer Drugs. 2003 Oct;14(9):669-82. Review.

PMID:
14551500
8.
9.

Insulin-like growth factors in human breast cancer.

Ellis MJ, Jenkins S, Hanfelt J, Redington ME, Taylor M, Leek R, Siddle K, Harris A.

Breast Cancer Res Treat. 1998;52(1-3):175-84. Review.

PMID:
10066081
10.

The role of the insulin-like growth factor-I receptor in cancer.

LeRoith D, Werner H, Neuenschwander S, Kalebic T, Helman LJ.

Ann N Y Acad Sci. 1995 Sep 7;766:402-8. Review. No abstract available.

PMID:
7486685
11.

Insulin-like growth factor I receptor signalling in prostate cancer cells.

Baserga R.

Growth Horm IGF Res. 2000 Apr;10 Suppl A:S43-4. Review. No abstract available.

PMID:
10984290
12.

IGF1R mutations as cause of SGA.

Klammt J, Kiess W, Pfäffle R.

Best Pract Res Clin Endocrinol Metab. 2011 Feb;25(1):191-206. doi: 10.1016/j.beem.2010.09.012. Review.

PMID:
21396585
14.

Insulin-like growth factor receptors: recent developments and new methodologies.

Roth RA, Kiess W.

Growth Regul. 1994 Feb;4 Suppl 1:31-8. Review. No abstract available.

PMID:
8205066
15.

Cathepsin D in cancer metastasis: a protease and a ligand.

Rochefort H, Liaudet-Coopman E.

APMIS. 1999 Jan;107(1):86-95. Review.

PMID:
10190284
16.

The role of the insulin-like growth factor I receptor in transformation and apoptosis.

Resnicoff M, Baserga R.

Ann N Y Acad Sci. 1998 Apr 15;842:76-81. Review. No abstract available.

PMID:
9599296
17.

The type 1 insulin-like growth factor receptor pathway.

Chitnis MM, Yuen JS, Protheroe AS, Pollak M, Macaulay VM.

Clin Cancer Res. 2008 Oct 15;14(20):6364-70. doi: 10.1158/1078-0432.CCR-07-4879. Review.

18.

The insulin-like growth factor system as a treatment target in breast cancer.

Yee D.

Semin Oncol. 2002 Jun;29(3 Suppl 11):86-95. Review.

PMID:
12138402
19.

[Dominant negative IGF-I receptor ].

Adachi Y, Min Y, Yamamoto H, Imai K.

Nihon Rinsho. 2003 Sep;61 Suppl 7:500-4. Review. Japanese. No abstract available.

PMID:
14574944
20.

The insulin-like growth factor (IGF) receptor type 1 (IGF1R) as an essential component of the signalling network regulating neurogenesis.

Annenkov A.

Mol Neurobiol. 2009 Dec;40(3):195-215. doi: 10.1007/s12035-009-8081-0. Epub 2009 Aug 29. Review.

PMID:
19714501

Supplemental Content

Support Center